SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten Ralph Lauren Q1 2026 Earnings EPS Beats Estimates Shares Edge Lower on Mixed Sentiment NATH Q4 2024 Earnings EPS of 096 Reported Amid Modest Stock Reaction AEMD Q1 2026 Earnings Slightly Better Than Expected Loss Amid No Revenue AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs OWLT Q1 2026 Earnings EPS Beat Surprises Market Amidst Operational Progress